- Home
- THAR vs BKYI Comparison
THAR vs BKYI Comparison
Compare THAR & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- BKYI
- Stock Information
- Founded
- THAR 2017
- BKYI 1993
- Country
- THAR United States
- BKYI United States
- Employees
- THAR N/A
- BKYI N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- BKYI Computer Software: Prepackaged Software
- Sector
- THAR Health Care
- BKYI Technology
- Exchange
- THAR Nasdaq
- BKYI Nasdaq
- Market Cap
- THAR 5.5M
- BKYI 4.8M
- IPO Year
- THAR 2022
- BKYI 1997
- Fundamental
- Price
- THAR $3.68
- BKYI $0.75
- Analyst Decision
- THAR Strong Buy
- BKYI
- Analyst Count
- THAR 1
- BKYI 0
- Target Price
- THAR $17.00
- BKYI N/A
- AVG Volume (30 Days)
- THAR 29.2M
- BKYI 127.4K
- Earning Date
- THAR 11-06-2025
- BKYI 08-13-2025
- Dividend Yield
- THAR N/A
- BKYI N/A
- EPS Growth
- THAR N/A
- BKYI N/A
- EPS
- THAR N/A
- BKYI N/A
- Revenue
- THAR N/A
- BKYI $6,911,148.00
- Revenue This Year
- THAR N/A
- BKYI $7.45
- Revenue Next Year
- THAR N/A
- BKYI $23.29
- P/E Ratio
- THAR N/A
- BKYI N/A
- Revenue Growth
- THAR N/A
- BKYI N/A
- 52 Week Low
- THAR $0.95
- BKYI $0.52
- 52 Week High
- THAR $9.08
- BKYI $3.68
- Technical
- Relative Strength Index (RSI)
- THAR 50.85
- BKYI 45.80
- Support Level
- THAR $4.94
- BKYI $0.71
- Resistance Level
- THAR $7.25
- BKYI $0.77
- Average True Range (ATR)
- THAR 1.50
- BKYI 0.04
- MACD
- THAR -0.08
- BKYI 0.00
- Stochastic Oscillator
- THAR 32.49
- BKYI 32.46
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.